Sponsored by


COVID lawsuits push doctors to provide substandard care

An appeals court ruling last week blocked a court order that could have required a Wisconsin hospital to go against its own protocols and provide a COVID-19 patient with a widely discredited and ineffective treatment.... Read more»

 1 2 >

Arizonans enroll in All of Us program to increase diversity in medical research

Arizona researchers are taking part in the All of Us program – an effort by the National Institutes of Health to collect data from at least 1 million people of different races, ages and backgrounds to help researchers find cures for a multitude of conditions.... Read more»

Biden administration details new research plan on 'long COVID' illness

The Biden administration announced plans Tuesday to create a national research action plan that could provide answers to public health officials trying to diagnose and treat so-called long COVID-19. ... Read more»

This scientist created a rapid test just weeks into the pandemic. Here’s why you still can’t get it.

Many companies with at-home COVID-19 tests have been stymied by an FDA review process that has flummoxed experts and even caused one agency reviewer to quit - tests experts say could have been a vital public health tool had they been produced in the millions in 2020.... Read more»


Researchers studying whether mouthwashes can reduce viral load, COVID transmission

In the laboratory, some mouthwashes used outside the U.S. have been shown to block infectivity or suppress SARS-CoV-2, but clinical trials involving people are not conclusive and researchers are continuing to study the matter, despite a claim by Sen. Ron Johnson.... Read more»


A guide to Pfizer/BioNTech’s pediatric COVID-19 vaccine for kids 5-11

Pfizer/BioNTech was the first to cross the finish line and offer a FDA-authorized COVID-19 vaccine to children ages 5 through 11. Here, FactCheck describes how it's different from its grown-up cousin and what experts are saying about who should get it.... Read more»

Valley fever vaccine for dogs shows promising results, first step toward human trials

A new Valley fever vaccine for dogs appears to provide a safe and effective defense against the fungal illness that sickens thousands of pets in Arizona each year, and marks a significant milestone that could lead to a similar vaccine for humans.... Read more»

Biden COVID data director on plugging deadly information gaps in a pandemic

Emergency physician Dr. Cyrus Shahpar is the White House’s COVID-19 data director and leads a team reporting to White House Coronavirus Response Coordinator Jeffrey Zients. In his first tweet on the new job, he announced that the Biden administration would release state pandemic reports that the previous administration refused to publish and that the Center for Public Integrity first uncovered and collected weekly to share with readers and local reporters. ... Read more»

TMC opens one of first COVID-19 'antibody infusion' treatment centers in U.S.

Tucson Medical Center and the Department of Health and Human Services on Thursday opened one of two treatment centers in the U.S. where COVID-19 patients can receive a specialized treatment to minimize the severity of illness and prevent some hospitalizations. ... Read more»

'Long-haulers' battle COVID-19 for months, but research into why is scant

Although most cases COVID-19 appear to be mild with a recovery time of a few weeks, health experts are seeing more patients who suffer symptoms for months or get better only to relapse down the road.... Read more»

Privacy fears rising as DNA test companies shift to new ventures

As genetic testing companies increasingly pivot to medical and pharmaceutical ventures, a regulatory gap in consumer privacy protections is drawing calls for change and even legislative proposals.... Read more»

COVID-19 vaccine trials having trouble recruiting Blacks, Latinos due to mistrust

Because of a long history of racism and unethical experimentation, people of color may be hesitant to participate in vaccine trials.... Read more»

NIH 'very concerned' about serious side effect in coronavirus vaccine trial

The FDA is weighing whether to follow British regulators in resuming a coronavirus vaccine trial that was halted when a participant suffered spinal cord damage, even as the National Institutes of Health has launched an investigation of the case.... Read more»

Unpacking Biden’s and Trump’s big cancer promises

On the campaign trail, former Vice President Joe Biden and President Donald Trump have both claimed that a cure to cancer would soon become a reality — if they were elected in 2020. Experts, however, don’t share that degree of optimism. ... Read more»

What the Devil won't tell you

Tucson economy faces cracks as UA research funding dries up

Cuts in state funding for the UA and stagnant federal research budgets are going to cost the Tucson economy and cost it a lot. $600 million in lost revenue is like losing two-thirds of Davis Monthan Air Force Base or 80 percent of the Raytheon Missile Systems payroll. It's like losing six Ventana Medical Systems.... Read more»2

Weed Rush

Gov't restrictions, lack of funding hinder MMJ research

Federal health agencies spend millions on pot science. But most money is spent on addiction research, not on the benefits. ... Read more»

 1 2 >